Literature DB >> 17457033

Nongenetic model of type 2 diabetes: a comparative study.

Md Shahidul Islam1, Haymie Choi.   

Abstract

Seven-week-old male Sprague-Dawley (SD) rats were divided into six groups (LFC, LFD, HFC, HFD30, HFD40, HFD50) to determine whether animals receiving a low-fat (LF) diet plus nicotinamide-streptozotocin (NA-STZ) injection or animals receiving a high-fat (HF) diet plus STZ injection provide a better model of type 2 diabetes. After 2 weeks of feeding, diabetes was induced by intraperitoneal injection of NA (230 mg/kg BW) and STZ (65 mg/kg BW) in LFD, and STZ 30, 40, 50 mg/kg BW to HFD30, HFD40, HFD50 groups, respectively. Fasting blood glucose at 48-72 h and nonfasting blood glucose at 1 week after STZ injection were >200 and >600 mg/dl, respectively, in HFD40 and HFD50 groups while no significant difference was observed among other groups. Serum insulin concentration was significantly (p < 0.05) decreased in LFD, HFC, HFD30, and HFD40 groups compared to LFC and HFD50 groups. One animal died and other animals of the HFD50 group were in a critical condition. Serum lipid and liver glycogen were increased in HFD groups compared to other groups. The results of this study suggest that the HF diet-fed, 40-mg/kg BW STZ-injected SD rat is better than the LF diet-fed NA-STZ-injected rat as an animal model of human type 2 diabetes. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457033     DOI: 10.1159/000101989

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  12 in total

1.  Impairment of brain mitochondrial charybdotoxin- and ATP-insensitive BK channel activities in diabetes.

Authors:  E Noursadeghi; A Jafari; R Saghiri; R Sauve; A Eliassi
Journal:  Neuromolecular Med       Date:  2014-10-26       Impact factor: 3.843

2.  Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.

Authors:  Hong Zhou; Yong-jun Li; Mian Wang; Li-hui Zhang; Bing-yan Guo; Zhan-sheng Zhao; Feng-ling Meng; Yong-gui Deng; Rui-ying Wang
Journal:  Acta Pharmacol Sin       Date:  2011-07-11       Impact factor: 6.150

3.  Development of a nongenetic mouse model of type 2 diabetes.

Authors:  Elizabeth R Gilbert; Zhuo Fu; Dongmin Liu
Journal:  Exp Diabetes Res       Date:  2011-11-29

4.  Gating behavior of endoplasmic reticulum potassium channels of rat hepatocytes in diabetes.

Authors:  Maedeh Ghasemi; Naser Khodaei; Sajjad Salari; Afsaneh Eliassi; Reza Saghiri
Journal:  Iran Biomed J       Date:  2014-07

5.  Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes.

Authors:  Valentina K Bayrasheva; Alina Yu Babenko; Vladimir A Dobronravov; Yuri V Dmitriev; Svetlana G Chefu; Ivan Yu Pchelin; Alexandra N Ivanova; Alekber A Bairamov; Nina P Alexeyeva; Ivan S Shatalov; Elena N Grineva
Journal:  J Diabetes Res       Date:  2016-12-20       Impact factor: 4.011

6.  Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats.

Authors:  DaoFei Song; Lei Yin; Chang Wang; XiuYing Wen
Journal:  PLoS One       Date:  2019-06-24       Impact factor: 3.240

7.  Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.

Authors:  Latt S Mansor; Eileen R Gonzalez; Mark A Cole; Damian J Tyler; Jessica H Beeson; Kieran Clarke; Carolyn A Carr; Lisa C Heather
Journal:  Cardiovasc Diabetol       Date:  2013-09-24       Impact factor: 9.951

8.  Epalrestat protects against diabetic peripheral neuropathy by alleviating oxidative stress and inhibiting polyol pathway.

Authors:  Qing-Rong Li; Zhuo Wang; Wei Zhou; Shou-Rui Fan; Run Ma; Li Xue; Lu Yang; Ya-Shan Li; Hong-Li Tan; Qing-Hua Shao; Hong-Ying Yang
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

9.  Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2.

Authors:  Jiayu Li; Rong Dong; Jiali Yu; Sun Yi; Jingjing Da; Fuxun Yu; Yan Zha
Journal:  Drug Des Devel Ther       Date:  2018-09-11       Impact factor: 4.162

10.  Dynamics of total volume of pancreatic α- and β -cells under the influence sulfonylureas and their combination with dipeptidyl peptidase-4 inhibitors.

Authors:  Tuchina Taisiia Pavlovna; Skotnikova Kseniia Petrovna; Vtorushina Anna Anatolievna; Uskov Ivan Sergeyevich; Rogoza Olga Vladimirovna; Grozov Roman Viktorovich; Babenko Alina Yurievna; Galagudza Mikhail Mikhailovich
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.